Español
English
Revista de Osteoporosis y Metabolismo Mineral 00104
/
http://dx.doi.org/10.20960/RevOsteoporosMetabMiner.00104
Resumen|
PDF
Artículo Especial
La paradoja de la PTH: una hormona con efectos contrapuestos sobre el esqueleto
Marta Martín Millán
Prepublicado: 2026-01-15
Número de descargas:
23
Número de visitas:
75
Citas:
0
Compártelo:
-
Palabras Clave: Hormona paratiroidea humana. Animales. Tiroides.
Owen R.,On the Anatomy of the Indian Rhinoceros (Rh. unicornis, L.). Zool Soc. 1852; IV:31-58.
DOI: 10.1111/j.1469-7998.1862.tb08046.x
DOI: 10.1111/j.1469-7998.1862.tb08046.x
SandströmIV, On a new gland in man and several mammals – glandulaeparathyroideae,UpsalaLäkFöreningsFörh. 1879-80;15:441-71.
Gley E., (1891),Sur Les fonctions du corps thyroid, CR SocBiol (Paris) 43: 841–847.
Erdheim J., (1906),Tetaniaparathyreopriva, Mitt a d Grenzgeb d Med u Chir 16:632–744
WGMaccallum, C Voegtlin,On the relation of tetany to the parathyroid glands and to calcium metabolism, JExp Med. 1909 Jan 9;11(1):118-51.
DOI: 10.1084/jem.11.1.118
DOI: 10.1084/jem.11.1.118
Collip JB., The extraction of a parathyroid hormone which will prevent or control parathyroid tetany and which regulates the level of blood calcium,JBiolChem Volume 63, 2, 1925: 395-438
DOI: 10.1016/S0021-9258(18)85007-4
DOI: 10.1016/S0021-9258(18)85007-4
Recklinghausen VF., (1891),DiefibröseoderdeformierendeOstitis, die Osteomalacie und die osteoplastischeCarcinose in IhrengegenseitigenBeziehungen,In: Festschrift R. Virchow zuseinem 71. Geburtstage. G. Reimer, Berlin
Jacob Erdheim,Tetaniaparathyreopriva, Mitt a d Grenzgeb d Med u Chir. 1906;16:632–744
Schlagenhaufer F., ZweiFälle von Parathyreoideatumoren. Wien Klin Wochenschr.1915; 28: 1362,
Mandl F., Attempt to treat generalized fibrous osteitis by extirpation of parathyroid tumor, Zentralbl F Chir; 1926;53:260– 264.
Albright F, Reifenstein EC Jr.,1948, The Parathyroid glands and metabolic bone disease: selected studies,Baltimore, MD: Williams & Wilkins.
Albright F, Bauer W, Ropes M, Aub JC: Studies of calcium and phosphorusmetabolism. IV. The effects of theparathyroid hormone. J Clin Invest 1929; 7: 139.
DOI: 10.1172/JCI100218
DOI: 10.1172/JCI100218
Bauer W, Aub JC, Albright F. Studies of calcium and Phosphorus metabolism: V. A study of the bone trabeculae as a readily available reserve supply of calcium. J ExpMed. 1929. 1;49(1):145-62
DOI: 10.1084/jem.49.1.145
DOI: 10.1084/jem.49.1.145
Cope, Oliver. The Story of Hyperparathyroidism at the Massachusetts General Hospital. N Engl J Med 1966;274:1174-1182
DOI: 10.1056/NEJM196605262742105
DOI: 10.1056/NEJM196605262742105
Donald Hunter, Joseph C. Aub. Lead Studies. XV. The Effect of the Parathyroid Hormone on the Excretion of Lead and of Calcium in Patients Suffering from Lead Poisoning. An International Journalof Medicine. 1927. 20 (78):123-140.
DOI: 10.1093/qjmed/os-20.78.123
DOI: 10.1093/qjmed/os-20.78.123
R. R. Hannon, E. Shorr, W. S. McClellan, E. F. DuBois .A case of osteitis fibrosa Cystica (Osteomalacia?) with evidence of hyperactivity of the para-thyroid bodies, Metabolic Study I.J Clin Invest. 1930;8(2):215-227. https://doi.org/10.1172/JCI100261.
DOI: 10.1172/JCI100261
DOI: 10.1172/JCI100261
Casper S. Inexplicable patients: the case of Charles Martell and Ward 4 at the Massachusetts General Hospital.CMAJ. 2016; 6;188(17-18):1263-1264.
DOI: 10.1503/cmaj.160111
DOI: 10.1503/cmaj.160111
Walter Bauer, Fuller Albright, Joseph C. Aub. A case of osteitis fibrosaCystica (Osteomalacia?) with evidence of hyperactivity of the para-thyroid bodies, Metabolic Study II.JClinInvest. 1930;8(2):229-248. https://doi.org/10.1172/JCI100262.
DOI: 10.1172/JCI100262
DOI: 10.1172/JCI100262
Selye Hans, On the stimulation of new bone-formation with parathyroid extract and irradiated ergosterol, Endocrinology, 16; 5, 1932: 547-558
DOI: 10.1210/endo-16-5-547
DOI: 10.1210/endo-16-5-547
L I Pugsley, H Selye The histological changes in the bone responsible for the action of parathyroid hormone on the calcium metabolism of the rat J Physiol. 1933. 28;79(1):113-7.
DOI: 10.1113/jphysiol.1933.sp003032
DOI: 10.1113/jphysiol.1933.sp003032
J A Parsons, B Reit., Chronic response of dogs to parathyroid hormone infusion,Nature 1974, 19;250(463):254-7.
DOI: 10.1038/250254a0
DOI: 10.1038/250254a0
J. Reeve, G. W. Tregear& J. A. Parsons,Preliminary Trial of Low Doses of Human Parathyroid Hormone 1–34 Peptide in Treatment of Osteoporosis, Calcified Tissues 1975
DOI: 10.1007/BF02546496
DOI: 10.1007/BF02546496
J Reeve et al., Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial, Br Med J. 1980;280(6228):1340-4.
DOI: 10.1136/bmj.280.6228.1340
DOI: 10.1136/bmj.280.6228.1340
R M Neer et al.,Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis, N Engl J Med. 2001.10;344(19):1434-41.
DOI: 10.1056/NEJM200105103441904
DOI: 10.1056/NEJM200105103441904
Martin TJ.,Historically significant events in the discovery of RANK/RANKL/OPG,World J Orthop. 2013, 18;4(4):186-97.
DOI: 10.5312/wjo.v4.i4.186
DOI: 10.5312/wjo.v4.i4.186
Robert L Jilka.,Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 2007;40(6):1434-46.
DOI: 10.1016/j.bone.2007.03.017
DOI: 10.1016/j.bone.2007.03.017
Robert L Jilka et al., Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts, Bone 2009;44(2):275-86.
DOI: 10.1016/j.bone.2008.10.037
DOI: 10.1016/j.bone.2008.10.037
Teresita Bellido et al., Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism, J BiolChem 2003, 12;278(50):50259-72.
DOI: 10.1074/jbc.M307444200
DOI: 10.1074/jbc.M307444200
Sang Wan Kim et al.,Intermittent parathyroid hormone administration converts quiescent lining cells to active osteoblasts, Journal of Bone and Mineral Research, 27, 10, 2012: 2075–2084.
DOI: 10.1002/jbmr.1665
DOI: 10.1002/jbmr.1665
T Bellido et al.,Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Endocrinology 2005;146(11):4577-83.
DOI: 10.1210/en.2005-0239
DOI: 10.1210/en.2005-0239
Michael Pazianas. Anabolic effects of PTH and the ‘anabolic window’.Trends in endocrinology and metabolism, 2015, 26;3: 111-113
DOI: 10.1016/j.tem.2015.01.004
DOI: 10.1016/j.tem.2015.01.004
Abou-Samra AB, Jüppner H, Force T, Freeman MW, Kong XF, Schipani E, et al. Structure, function, and expression of the receptor for parathyroid hormone and parathyroid hormone-related peptide. Adv Nephrol Necker Hosp. 1994;23:247-64.
Martin TJ, Sims NA, Seeman E. Physiological and pharmacological roles of PTH and PTHrP in bone using their shared receptor, PTH1R. Endocr Rev. 2021;42(4):383-406.
DOI: 10.1210/endrev/bnab005
DOI: 10.1210/endrev/bnab005
Esbrit P. Papel de la proteína relacionada con la parathormona (PTHrP) en el metabolismo óseo: de la investigación básica a la clínica. Rev OsteoporosMetab Miner. 2023;15(1):1-5.
Wein MN, Kronenberg HM. Regulation of bone remodeling by parathyroid hormone. Cold Spring Harb Perspect Med. 2018;8(8):a031237.
DOI: 10.1101/cshperspect.a031237
DOI: 10.1101/cshperspect.a031237
Ardura JA, Portal-Núñez S, Alonso V, Bravo B, Gortazar AR. Handling parathormone receptor type 1 in skeletal diseases: realities and expectations of abaloparatide. Trends Endocrinol Metab. 2019;30(10):756-66.
DOI: 10.1016/j.tem.2019.07.014
DOI: 10.1016/j.tem.2019.07.014
Wein MN, Foretz M, Fisher DE, Xavier RJ, Kronenberg HM. Salt-inducible kinases: physiology, regulation by cAMP, and therapeutic potential. Trends Endocrinol Metab. 2018;29(10):723-35.
DOI: 10.1016/j.tem.2018.08.004
DOI: 10.1016/j.tem.2018.08.004
Dean T, Vilardaga JP, Potts JT Jr, Gardella TJ. Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH/PTHrP receptor. Mol Endocrinol. 2008;22(1):156-66.
DOI: 10.1210/me.2007-0274
DOI: 10.1210/me.2007-0274
Vilardaga JP, Romero G, Krasel C, Seifert R, GardellaTJ. Molecular mechanisms of PTH/PTHrP class B GPCR signaling and pharmacological implications. Endocr Rev. 2023;44(3):474-91.
DOI: 10.1210/endrev/bnac032
DOI: 10.1210/endrev/bnac032
Okazaki M, Ferrandon S, Vilardaga JP, Bouxsein ML, Potts JT Jr, Gardella TJ. Prolonged signaling at the parathyroid hormone receptor by peptide ligands targeted to a specific receptor conformation. Proc Natl Acad Sci U S A. 2008;105(44):16525-30.
DOI: 10.1073/pnas.0808750105
DOI: 10.1073/pnas.0808750105
Ferrandon S, Feinstein TN, Castro M, Wang B, Bouley R, Potts JT, et al. Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. Nat Chem Biol. 2009;5(9):734-42.
DOI: 10.1038/nchembio.206
DOI: 10.1038/nchembio.206
Hattersley G, Dean T, Corbin BA, Bahar H, Gardella TJ. Binding selectivity of abaloparatide for PTH-type-1-receptor conformations and effects on downstream signaling. Endocrinology. 2016;157(1):141-9.
DOI: 10.1210/en.2015-1726
DOI: 10.1210/en.2015-1726
Peña KA. Endosomal parathyroid hormone receptor signaling. Am J Physiol Cell Physiol. 2022;323(6):C783-90.
DOI: 10.1152/ajpcell.00452.2021
DOI: 10.1152/ajpcell.00452.2021
Feinstein TN, Wehbi VL, Ardura JA, Wheeler DS, Ferrandon S, Gardella TJ, et al. Retromer terminates the generation of cAMP by internalized PTH receptors. Nat Chem Biol. 2011;7(5):278-84.
DOI: 10.1038/nchembio.545
DOI: 10.1038/nchembio.545
Miller PD, Hattersley G, Riis BJ, Williams GC, Lau E, Russo LA, et al; ACTIVE Study Investigators. Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial. JAMA. 2016;316(7):722-33.
DOI: 10.1001/jama.2016.11136
DOI: 10.1001/jama.2016.11136
Artículos Relacionados:
Revisión: Protocolo de diagnóstico y manejo de hipocalcemia en postoperatorio de tiroides
Publicado: 2023-03-01 / http://dx.doi.org/10.4321/S1889-836X2020000200006
Trabajo Original: Efectos divergentes de la inhibición de TGF-ß en metástasis óseas de cáncer de mama y pulmón
Publicado: 2023-03-01 / http://dx.doi.org/
Revisión: Hormonas tiroideas, TSH, cáncer de tiroides y hueso en mujeres pre y postmenopáusicas
Publicado: 2023-03-02 / http://dx.doi.org/10.4321/S1889-836X2017000200006
Trabajo Original: Hipometilación del gen de la PTH por elevado fósforo de la dieta: un posible agravante epigenético de la severidad del hiperparatiroidismo secundario en la enfermedad renal crónica
Publicado: 2023-03-02 / http://dx.doi.org/10.4321/S1889-836X2017000400003
Nota Clínica: Metástasis óseas y compresión medular como debut de carcinoma folicular de tiroides
Publicado: 2023-03-03 / http://dx.doi.org/
Artículos más populares
Revisión: Acción de la cerveza sobre el hueso
Aunque se ha demostrado que el exceso de alcohol e...
Trabajo Original: Resumen ejecutivo de las guías de práctica clínica en la osteoporosis postmenopáusica, glucocorticoidea y del varón (actualización 2022). SEIOMM
Esta versión actualizada de la Guía de osteoporosi...
-
Licencia creative commons: Open Access bajo la licencia Creative Commons 4.0 CC BY-NC-SA
https://creativecommons.org/licenses/by-nc-sa/4.0/legalcode
Editado en Madrid por:
